BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19183876)

  • 1. Anti-androgen-independent prostate cancer effects of ginsenoside metabolites in vitro: mechanism and possible structure-activity relationship investigation.
    Li W; Liu Y; Zhang JW; Ai CZ; Xiang N; Liu HX; Yang L
    Arch Pharm Res; 2009 Jan; 32(1):49-57. PubMed ID: 19183876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.
    Wang W; Zhao Y; Rayburn ER; Hill DL; Wang H; Zhang R
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):589-601. PubMed ID: 16924497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
    Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
    Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antiproliferation in prostate cancer cell lines with cytostatics and combinations with resistance modifiers.
    Pintér O; Mucsi I; Molnár J
    In Vivo; 2005; 19(1):253-9. PubMed ID: 15796183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferruginol suppresses survival signaling pathways in androgen-independent human prostate cancer cells.
    Bispo de Jesus M; Zambuzzi WF; Ruela de Sousa RR; Areche C; Santos de Souza AC; Aoyama H; Schmeda-Hirschmann G; Rodríguez JA; Monteiro de Souza Brito AR; Peppelenbosch MP; den Hertog J; de Paula E; Ferreira CV
    Biochimie; 2008 Jun; 90(6):843-54. PubMed ID: 18294971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
    Liu SJ; Xu KX; Wang XF; Hou SK; Wang YC
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):604-6. PubMed ID: 15265404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization.
    Petrangeli E; Lenti L; Buchetti B; Chinzari P; Sale P; Salvatori L; Ravenna L; Lococo E; Morgante E; Russo A; Frati L; Di Silverio F; Russo MA
    J Cell Physiol; 2009 Apr; 219(1):69-76. PubMed ID: 19067321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.
    Popovich DG; Kitts DD
    Can J Physiol Pharmacol; 2004 Mar; 82(3):183-90. PubMed ID: 15052284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
    Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.
    Singh RK; Lokeshwar BL
    Mol Cancer; 2009 Jul; 8():57. PubMed ID: 19646263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145.
    Floryk D; Huberman E
    Cancer Lett; 2006 Jan; 231(1):20-9. PubMed ID: 16356827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].
    Cao M; Yu HS; Song XB; Ma BP
    Yao Xue Xue Bao; 2012 Jul; 47(7):836-43. PubMed ID: 22993845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mTOR inhibitor enhances chemosensitivity of androgen-independent prostate cancer cell line].
    Xia JS; Chen XG; Zhuang QY; Liu JH; Ye ZQ
    Zhonghua Nan Ke Xue; 2009 Jul; 15(7):617-20. PubMed ID: 19694375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
    Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
    Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.